A polymorphic CD40 ligand (CD154) molecule mediates CD40-dependent signalling but interferes with the ability of soluble CD40 to functionally block CD154:CD40 interactions

Immunology

Volumn 99, Issue 1, 2000, Pages 54-61

  Barnhart, B ^a   Ford, G S ^a   Bhushan, A ^a   Song, C ^b   Covey, L R ^a,c  

^a RUTGERS UNIVERSITY   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GLYCOPROTEIN GP 39;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; SIGNAL TRANSDUCTION;

ANTIGENS, CD40; ANTIGENS, CD80; CD40 LIGAND; COCULTURE TECHNIQUES; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; POLYMORPHISM, GENETIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0033957996     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00943.x     Document Type: Article

References (30)

1. 1. Banchereau J., Bazan K., Blanchard D. et al. (1994) The CD40 antigen and its ligand. Ann Rev Immunol 12, 881.
2. 2. Kawabe T., Naka T., Yishida K. et al. (1994) The immune response in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1, 167.
3. 3. Xu J., Foy T.M., Laman J.D. et al. (1994) Mice deficient for the CD40 ligand. Immunity 1, 423.
4. 4. Krozek R.A., Graf D., Brugnoni D. et al. (1994) Defective expression of CD40 ligand on T cells causes X-linked immunodeficiency with hyper-IgM (HIGM1). Immunol Rev 138, 39.
5. 5. Jenkins M.K. (1994) The ups and downs of T cell co-stimulation. Immunity 1, 443.
6. 6. Janeway C.A. Jr & Bottomly K. (1994) Signals and signs for lymphocyte responses. Cell 76, 275.
7. 7. Grewal I.S. & Flavell R.A. (1996) CD40 CD40L interactions in T cell activation. Immunol Rev 153, 85.
8. 8. Ranheim E.A. & Kipps T.J. (1993) Activated T cells induce expression of B7/BBI on normal or leukemic B cells through a CD40-depcndent signal. J Exp Med 177, 925.
9. 9. Yellin M.J., Sippel K., Inghirami G. et al. (1994)T lymphocyteT cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80(B7/BB-I) and enhance their costimulatory activity. J Immunol 153, 666.
10. 10. Roy M., Aruffo A., Ledbetter J.A., Linsley P., Kehry M. & Noelle R. (1994) Studies on the independence of gp39 and B7 expression and function during antigen-specific immune responses. Eur J Immunol 25, 596.
11. 11. Grewal I.S. & Flavell R.A. (1998) CD40 and CD154 in cell-mediated immunity. Ann Rev Immunol 16, 111.
12. 12. Larsen C.P., Elwood E.T., Alexander D.Z. et al. (1996) Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381, 434.
13. 13. Hancock W.W., Sayegh M.H., Zheng X.G., Peach R., Linsley P.S. & Turka L.A. (1996) Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci USA 93, 13967.
14. 14. Kirk A.D., Harlan D.M., Armstrong N.N. et al. (1997) CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci USA 94, 8789.
15. 15. Lin Q., Rohrer J., Allen R.C. et al. (1996) A single strand conformation polymorphism study of CD40 ligand. J Clin Invest 97, 196.
16. 16. Klein G., Giovanella B., Westman A., Stehlin J.S. & Mumford D. (1975) An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology 5, 319.
17. 17. Siegel J.P. & Mostowski H.S. (1990) A bioassay for the measurement of human interleukin-4. J Immunol Methods 132, 287.
18. 18. Korthauer U., Graf D., Mages H.W. et al. (1993) Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361, 539.
19. + T cells that induces contact-dependent B cell differentiation (Help). J Exp Med 175, 1092.
20. + T cells mediating contact-dependent helper function for B cells: identity with the CD40-ligand. Mol Immunol 31, 471.
21. 21. Spriggs M.K., Armitage R.J., Strockbine L. et al. (1992) Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med 176, 1543.
22. + human B cell lymphoma line. J Immunol 160, 595.
23. 23. Lane P., Traunecker A., Inui S., Lanzavecchia A. & Gray D. (1992) Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol 22, 2573.
24. 24. Lederman S., Yellin M.J., Inghirami G., Lee J.J., Knowles D.M. & Chess L. (1992) Molecular interactions mediating T B lymphocyte collaboration in human lymphoid follicles. J Immunol 149, 3817.
25. 25. Karpusas M., Hsu Y.-M., Wang J.-H. et al. (1995) 2A crystal structure of an extracellular fragment of human CD40 ligand. Structure 3, 1031.
26. 26. Singh J., Garber E., Van Vlumen H. et al. (1998) The role of polar interactions in the molecular recognition of CD40L with its receptor CD40. Protein Sci 7, 1124.
27. 27. Bajorath J., Marken J.S., Chalupny N.J. et al. (1995) Analysis of gp39/CD40 interactions using molecular models and site-directed mutagenesis. Biochemistry 34, 9884.
28. 28. Bajorath J., Chalupny N.J., Marken J.S. et al. (1995) Identification of residues on CD40 and its ligand which are critical for the receptor ligand interaction. Biochemistry 34, 1833.
29. 29. Callard R.E., Smith S.H., Herbert J. et al. (1994) CD40 ligand (CD40L) expression and B cell function in agammaglobulinemia with normal or elevated levels of IgM (HIM). J Immunol 153, 3295.
30. 30. Durie F.H., Fava R.A., Foy T.M., Aruffo A., Ledbetter J.A. & Noelle R.J. (1993) Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261, 1328.